Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:13:21.766Z.
Calculation as of: 2026-10-06T19:13:21.766Z.
Quote observation: 2026-10-06T19:10:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 371c12db8760855cbd67a4f629ef705ee3b50919edbb0a0fc68f9f6d9159db17
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Quanterix Corporation
Market Cap
$163.28M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$163.00M
Free Cash Flow Yield
N/A
TTM Avg
0.52%
3Y Avg
0.52%
5Y Avg
7.43%
Market Cap
$165.88M
Free Cash Flow Yield
11.07%
TTM Avg
9.84%
3Y Avg
5.75%
5Y Avg
5.19%
Market Cap
$160.03M
Free Cash Flow Yield
N/A
TTM Avg
1.28%
3Y Avg
1.28%
5Y Avg
1.28%
Market Cap
$168.97M
Free Cash Flow Yield
N/A
TTM Avg
12.80%
3Y Avg
12.80%
5Y Avg
12.80%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quanterix Corporation (QTRX) | $163.28M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $163.00M | N/A | 0.52% | 0.52% | 7.43% |
| PepGen Inc. (PEPG)vs › | $160.13M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.88M | 11.07% | 9.84% | 5.75% | 5.19% |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.03M | N/A | 1.28% | 1.28% | 1.28% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | N/A | 0.73% | 0.67% | 0.67% |
| Nkarta, Inc. (NKTX)vs › | $165.99M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $168.97M | N/A | 12.80% | 12.80% | 12.80% |
| Inogen, Inc. (INGN)vs › | $156.90M | N/A | 1.49% | 2.55% | 2.12% |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.84M | 12.27% | 7.35% | 3.01% | 3.15% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute